Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium

Dr Jaffer A Ajani from The University of Texas MD Anderson Cancer Center in Houston, Dr Rutika Mehta from Weill Cornell Medicine in New York, New York, Dr John Strickler from Duke University in Durham, North Carolina, and moderator Dr Samuel J Klempner from Massachusetts General Hospital in Boston review data supporting immunotherapy for gastroesophageal cancers and findings presented at the 2026 ASCO Gastrointestinal Cancers Symposium. CME information and select publications here.